News

Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.

By Barbara J. Toman • January 17, 2023

Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly slow disease

By Samantha Rossi • January 13, 2023

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.

By Carly Mouzes • January 11, 2023

Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. 

By Suzanne Ferguson • January 10, 2023

Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.

By Kelley Luedke • January 6, 2023

Topic highlights include: Public health agencies try to restore trust as they fight misinformation, Telehealth brings expert sexual assault exams to rural patients, FDA decision on experimental Alzheimer’s drug expected this week.

By Samantha Rossi • January 6, 2023

In December 2022, Mayo Clinic Laboratories announced seventy-eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Samantha Rossi • January 5, 2023

Due to logistic challenges, we are experiencing shipment delays which may result in testing delays or cancelations.

By Mayo Clinic Laboratories • January 3, 2023

Topic highlights include: Biden administration releases doses of flu medicine from national stockpile and pediatric medicine makers say they are running 24/7 to meet increased demand

By Samantha Rossi • December 30, 2022

As a result of winter weather across the U.S. and the upcoming holiday this weekend, we are experiencing logistical challenges, which may result in testing delays or cancelations.

By Mayo Clinic Laboratories • December 23, 2022

Topic highlights include: New members-only health clinic to start seeing Rochester patients in January, A staffing expert shows how telehealth is stepping in to fill the staffing shortage, Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness

By Samantha Rossi • December 23, 2022

Due to the Christmas and New Year's holiday's (recognized on Sunday, December 25th, and Sunday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

By Samantha Rossi • December 21, 2022

Effective Jan. 2, U.S. Customs and Border Protection will enhance the enforcement of the Centers for Disease Control and Prevention (CDC) requirements on the importation of biological specimens. Please include the CDC permit within your shipment. Failure to comply will result in your shipment being denied admissibility by U.S. Customs and Border Protection. If an entry is denied, the carrier is required to return or destroy the shipment.

By Mayo Clinic Laboratories • December 20, 2022